Modelling the impact and incremental cost-effectiveness of introducing vaccines againtst hepatitis B Haemophilus influenzae type b and rotavirus into routine infant immunization programmes in Bangladesh and Peru

Full metadata record
DC FieldValueLanguage
dc.contributor.authorAli, Disha-
dc.contributor.authorAkramuzzaman, S.M.-
dc.date.accessioned2014-02-06T09:22:38Z-
dc.date.available2014-02-06T09:22:38Z-
dc.date.issued2000-
dc.identifier.urihttp://hdl.handle.net/123456789/4906-
dc.format.extent2033305 bytes-
dc.format.mimetypeapplication/pdf-
dc.language.isoenen
dc.relation.ispartofseriesICDDRB Research Protocolen
dc.relation.ispartofseriesno. 2000-017en
dc.subjectCost-Benefit Analysisen
dc.subjectHaemophilus influenzae type ben
dc.subjectClinical Protocolsen
dc.subjectRotavirus Infectionsen
dc.subjectRotavirus Vaccinesen
dc.subjectDeveloping Countriesen
dc.titleModelling the impact and incremental cost-effectiveness of introducing vaccines againtst hepatitis B Haemophilus influenzae type b and rotavirus into routine infant immunization programmes in Bangladesh and Peruen
dc.typeOtheren
Appears in Collections:Infectious diseases and vaccine sciences research protocols

Files in This Item:
File Description SizeFormat 
ICDDRBProtocol-2000-017.pdf1.99 MBAdobe PDFView/Open


This item is protected by original copyright